Sugiura Y, Ohashi Y, Nakai Y
Department of Otolaryngology, Osaka City University Medical School, Japan.
Acta Otolaryngol Suppl. 1997;531:17-20. doi: 10.3109/00016489709126132.
Mucociliary dysfunction in the tubotympanum is deeply reflected in the clinical manifestations of otitis media with effusion (OME), and clinical application of pharmacological agents with ciliostimulatory action might therefore enhance the mucociliary clearance function of the tubotympanum to more effectively eliminate middle ear effusions to the pharynx. A herbal medicine, sairei-to, enhances the in vitro ciliary activity of the middle ear during culture. However, this ciliostimulatory effect is not always applicable to the mucociliary system in situ, which may be deteriorated following oral administration of sairei-to. The present study therefore aimed at investigating the in vivo effect of sairei-to on the mucociliary system in the tubotympanum of the guinea pig. Thirty healthy guinea pigs were used. Ten animals were treated with oral administration of physiologic saline solution for 14 successive days. The remaining animals were treated with oral administration of 120 or 600 mg/kg body weight of sairei-to for 14 successive days. Each animal was used for examination of the ciliary activity and mucociliary clearance time of the tubotympanum, 24 h after the final treatment. No significant changes in either ciliary activity or mucociliary clearance time of the tubotympanum were observed upon administration of 120 mg/kg of sairei-to, which was equivalent to the clinical human dosage. By contrast, oral administration of 600 mg/kg of sairei-to significantly enhanced the ciliary activity, but failed to significantly accelerate mucociliary clearance in the tubotympanum, although the mean value of the clearance time became shorter. Therefore, our results suggest that sairei-to to some extent stimulates the function of the mucociliary system. In conclusion, the herbal medicine, sairei-to, might be useful in the treatment of OME, and preventive administration of this drug may be a new therapy in the treatment of recurrent OME.
鼓室的黏液纤毛功能障碍在分泌性中耳炎(OME)的临床表现中得到深刻体现,因此,具有纤毛刺激作用的药物的临床应用可能会增强鼓室的黏液纤毛清除功能,从而更有效地将中耳积液排至咽部。一种草药,柴苓汤,可增强培养过程中中耳的体外纤毛活性。然而,这种纤毛刺激作用并不总是适用于原位的黏液纤毛系统,口服柴苓汤后该系统可能会恶化。因此,本研究旨在探讨柴苓汤对豚鼠鼓室黏液纤毛系统的体内作用。使用了30只健康豚鼠。10只动物连续14天口服生理盐水溶液。其余动物连续14天口服120或600mg/kg体重的柴苓汤。在最后一次治疗后24小时,对每只动物进行鼓室纤毛活性和黏液纤毛清除时间的检查。给予相当于临床人体剂量的120mg/kg柴苓汤后,鼓室的纤毛活性或黏液纤毛清除时间均未观察到显著变化。相比之下,口服600mg/kg柴苓汤可显著增强纤毛活性,但未能显著加速鼓室的黏液纤毛清除,尽管清除时间的平均值变短。因此,我们的结果表明柴苓汤在一定程度上刺激了黏液纤毛系统的功能。总之,草药柴苓汤可能对OME的治疗有用,预防性给予这种药物可能是治疗复发性OME的一种新疗法。